Oncology Research2026，Vol.34Issue(8)：P.102-123,22.DOI:10.32604/or.2026.078924
Navigating the Metabolic-Genomic Paradigm:Mitochondrial Reprogramming as a Driver of Cancer Plasticity
Yen-Dun Tony Tzeng 1Chen-Yueh Wen 2Su-Boon Yong 3Zhi-Hong Wen 4An-Jen Chiang 5Chia-Jung Li6
作者信息
- 1. Department of Surgery,Kaohsiung Veterans General Hospital,Kaohsiung,Taiwan Center of General Education,Shu-Zen Junior College of Medicine and Management,Kaohsiung,Taiwan
- 2. Division of Urology,Show Chwan Memorial Hospital,Changhua,Taiwan Division of Urology,Chang Bing Show Chwan Memorial Hospital,Changhua,Taiwan
- 3. Department of Allergy and Immunology,China Medical University Children’s Hospital,Taichung,Taiwan Research Center for Allergy,Immunology,and Microbiome(A.I.M.),China Medical University Hospital,Taichung,Taiwan
- 4. Department of Marine Biotechnology and Resources,National Sun Yat-sen University,Kaohsiung,Taiwan National Museum of Marine Biology&Aquarium,Pingtung,Taiwan
- 5. Department of Medical Education and Research,Kaohsiung Veterans General Hospital Kaohsiung,Kaohsiung,Taiwan
- 6. National Museum of Marine Biology&Aquarium,Pingtung,Taiwan Department of Obstetrics and Gynecology,Kaohsiung Veterans General Hospital,Kaohsiung,Taiwan Center of General Education,Cheng Shiu University,Kaohsiung,Taiwan Institute of BioPharmaceutical Sciences,National Sun Yat-sen University,Kaohsiung,Taiwan
- 折叠
摘要
关键词
Breast cancer(BC)/precision medicine/metabolic reprogramming/therapeutic resistance/artificial intelligence(AI)分类
医药卫生引用本文复制引用
Yen-Dun Tony Tzeng,Chen-Yueh Wen,Su-Boon Yong,Zhi-Hong Wen,An-Jen Chiang,Chia-Jung Li..Navigating the Metabolic-Genomic Paradigm:Mitochondrial Reprogramming as a Driver of Cancer Plasticity[J].Oncology Research,2026,34(8):P.102-123,22.基金项目
funded by the National Science and Technology Council(NTSC 114-2628-B075B-001-MY3 and 114-2314-B-075B-013) （NTSC 114-2628-B075B-001-MY3 and 114-2314-B-075B-013）
Kaohsiung Veterans General Hospital(114-090,114-048). （114-090,114-048）
